Emergent BioSolutions Inc. (LON:0IGA)
London · Delayed Price · Currency is GBP · Price in USD 10.58
-0.23 (-2.13%)
Feb 9, 2026, 7:03 PM GMT
Emergent BioSolutions Market Cap
Emergent BioSolutions has a market cap or net worth of 423.78 million as of February 10, 2026. Its market cap has decreased by -16.22% in one year.
Market Cap
423.78M
Enterprise Value
735.06M
Revenue
586.89M
Ranking
n/a
PE Ratio
7.51
Stock Price
10.58
Market Cap Chart
Since November 15, 2006, Emergent BioSolutions's market cap has increased from 169.95M to 423.78M, an increase of 149.35%. That is a compound annual growth rate of 4.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 423.78M | -12.14% |
| Dec 31, 2025 | 482.32M | 16.57% |
| Dec 31, 2024 | 413.76M | 323.24% |
| Dec 29, 2023 | 97.76M | -80.01% |
| Dec 30, 2022 | 488.99M | -71.69% |
| Dec 31, 2021 | 1.73B | -50.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 218.75B |
| GSK plc | 88.21B |
| Haleon | 35.46B |
| Smith & Nephew | 10.77B |
| Allergy Therapeutics | 669.42M |
| Craneware | 550.62M |
| Advanced Medical Solutions Group | 468.25M |
| PureTech Health | 305.97M |